Skip to main content
PMC home page
Gut logoLink to Gut
. 1983 Jul;24(7):631–636. doi: 10.1136/gut.24.7.631

Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism.

M Borzio, R Caldara, F Borzio, V Piepoli, P Rampini, C Ferrari
PMCID: PMC1420033  PMID: 6407905

Abstract

To further evaluate thyroid function in patients with liver disease, we have measured total and free T3 and T4, thyroxine binding globulin, basal and thyrotropin releasing hormone-stimulated thyrotropin and thyroglobulin antibodies in 33 patients with liver cirrhosis, in 22 with chronic hepatitis and in 30 healthy controls. All the patients but one were clinically euthyroid. T3, FT3, T3/thyroxine binding globulin and T4/thyroxine binding globulin ratios and thyrotropin after thyrotropin releasing hormone were significantly reduced, while FT4, thyroxine binding globulin and thyrotropin were significantly increased in liver cirrhosis. In chronic hepatitis group, FT3 and T3/thyroxine binding globulin ratio were significantly lower and thyroxine binding globulin and FT4 were higher than in healthy controls. The between patients comparison revealed a significantly lower T3, FT3, T3/thyroxine binding globulin and T4/thyroxine binding globulin ratios and delta thyrotropin in cirrhotics. Thyroglobulin antibodies were present at high titre only in two patients one of whom having evidence of Hashimoto's thyroiditis with subclinical hypothyroidism. The correlation coefficient between T4/thyroxine binding globulin ratio and FT4 were lower in patients than in controls. Furthermore an abnormal thyrotropin response to thyrotropin releasing hormone was shown in 10 cirrhotics and in four patients with chronic hepatitis. Serum T3 significantly correlated with serum bilirubin, albumin, and prothrombin time in both groups of patients. The present data confirm the existence of several abnormalities of thyroid function tests in patients with chronic liver disease, although showing that euthyroidism is almost always maintained, probably as a result of low-normal FT3 and high-normal FT4. Furthermore, T3 serum levels appear to parallel the severity of liver dysfunction.

Full text

PDF
636

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bermudez F., Surks M. I., Oppenheimer J. H. High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease. J Clin Endocrinol Metab. 1975 Jul;41(1):27–40. doi: 10.1210/jcem-41-1-27. [DOI] [PubMed] [Google Scholar]
  2. Borzio M., Caldara R., Ferrari C., Barbieri C., Borzio F., Romussi M. Growth hormone and prolactin secretion in liver cirrhosis: evidence for dopaminergic dysfunction. Acta Endocrinol (Copenh) 1981 Aug;97(4):441–447. doi: 10.1530/acta.0.0970441. [DOI] [PubMed] [Google Scholar]
  3. Chopra I. J., Solomon D. H., Chopra U., Young R. T., Chua Teco G. N. Alterations in circulating thyroid hormones and thyrotropin in hepatic cirrhosis: evidence for euthyroidism despite subnormal serum triiodothyronine. J Clin Endocrinol Metab. 1974 Sep;39(3):501–511. doi: 10.1210/jcem-39-3-501. [DOI] [PubMed] [Google Scholar]
  4. Chopra I. J., Solomon D. H., Hepner G. W., Morgenstein A. A. Misleadingly low free thyroxine index and usefulness of reverse triiodothyronine measurement in nonthyroidal illnesses. Ann Intern Med. 1979 Jun;90(6):905–912. doi: 10.7326/0003-4819-90-6-905. [DOI] [PubMed] [Google Scholar]
  5. Chopra I. J., Teco G. N., Nguyen A. H., Solomon D. H. In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroid illnesses. J Clin Endocrinol Metab. 1979 Jul;49(1):63–69. doi: 10.1210/jcem-49-1-63. [DOI] [PubMed] [Google Scholar]
  6. Crowe J. P., Christensen E., Butler J., Wheeler P., Doniach D., Keenan J., Williams R. Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology. 1980 Jun;78(6):1437–1441. [PubMed] [Google Scholar]
  7. Fischer J. E., Baldessarini R. J. False neurotransmitters and hepatic failure. Lancet. 1971 Jul 10;2(7715):75–80. doi: 10.1016/s0140-6736(71)92048-4. [DOI] [PubMed] [Google Scholar]
  8. Geurts J., Demeester-Mirkine N., Glinoer D., Prigogine T., Fernandez-Deville M., Corvilain J. Alterations in circulating thyroid hormones and thyroxine binding globulin in chronic alcoholism. Clin Endocrinol (Oxf) 1981 Feb;14(2):113–118. doi: 10.1111/j.1365-2265.1981.tb00605.x. [DOI] [PubMed] [Google Scholar]
  9. Green J. R., Snitcher E. J., Mowat N. A., Ekins R. P., Rees L. H., Dawson A. M. Thyroid function and thyroid regulation in euthyroid men with chronic liver disease: evidence of multiple abnormalities. Clin Endocrinol (Oxf) 1977 Dec;7(6):453–461. doi: 10.1111/j.1365-2265.1977.tb01337.x. [DOI] [PubMed] [Google Scholar]
  10. Hepner G. W., Chopra I. J. Serum thyroid hormone levels in patients with liver disease. Arch Intern Med. 1979 Oct;139(10):1117–1120. [PubMed] [Google Scholar]
  11. Israel Y., Walfish P. G., Orrego H., Blake J., Kalant H. Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil. Gastroenterology. 1979 Jan;76(1):116–122. [PubMed] [Google Scholar]
  12. L'age M., Meinhold H., Wenzel K. W., Schleusener H. Relations between serum levels of TSH, TBG, T4, T3, rT3 and various histologically classified chronic liver diseases. J Endocrinol Invest. 1980 Oct-Dec;3(4):379–383. doi: 10.1007/BF03349374. [DOI] [PubMed] [Google Scholar]
  13. Larsen P. R. Direct immunoassay of triiodothyronine in human serum. J Clin Invest. 1972 Aug;51(8):1939–1949. doi: 10.1172/JCI107000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Levy R. P., Marshall J. S., Velayo N. L. Radioimmunoassay of human thyroxine-binding globulin (TBG). J Clin Endocrinol Metab. 1971 Mar;32(3):372–381. doi: 10.1210/jcem-32-3-372. [DOI] [PubMed] [Google Scholar]
  15. Nomura S., Pittman C. S., Chambers J. B., Jr, Buck M. W., Shimizu T. Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis. J Clin Invest. 1975 Sep;56(3):643–652. doi: 10.1172/JCI108134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Odell W. D., Rayford P. L., Ross G. T. Simplified, partially automated method for radioimmunoassay of human thyroid-stimulating, growth, luteinizing, and follicle stimulating hormones. J Lab Clin Med. 1967 Dec;70(6):973–980. [PubMed] [Google Scholar]
  17. Romelli P. B., Pennisi F., Vancheri L. Measurement of free thyroid hormones in serum by column adsorption chromatography and radioimmunoassay. J Endocrinol Invest. 1979 Jan-Mar;2(1):25–40. doi: 10.1007/BF03349272. [DOI] [PubMed] [Google Scholar]
  18. Scanlon M. F., Pourmand M., McGregor A. M., Rodriguez-Arnao M. D., Hall K., Gomez-Pan A., Hall R. Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin. J Endocrinol Invest. 1979 Jul-Sep;2(3):307–331. doi: 10.1007/BF03350424. [DOI] [PubMed] [Google Scholar]
  19. Schussler G. C., Schaffner F., Korn F. Increased serum thyroid hormone binding and decreased free hormone in chronic active liver disease. N Engl J Med. 1978 Sep 7;299(10):510–515. doi: 10.1056/NEJM197809072991003. [DOI] [PubMed] [Google Scholar]
  20. Woeber K. A., Maddux B. A. Thyroid hormone binding in nonthyroid illness. Metabolism. 1981 Apr;30(4):412–416. doi: 10.1016/0026-0495(81)90124-4. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES